SPECIALTY TOPICS · GUIDE
Pulsed Electromagnetic Field Therapy
What pulsed electromagnetic field (PEMF) therapy is, its U.S. regulatory status for bone healing and postoperative pain, and what reviews show for osteoarthritis, back pain and fractures.
Content last updated . This page has not been medically reviewed.
Back to Emerging Wellness ScienceEvidence labels: cleared or approved device (named use), established, promising but limited, mixed, insufficient evidence, no good evidence of benefit, marketing claim.
Do not mix up neighboring technologies
PEMF is not the same as the magnetic stimulation of the brain used in depression care (see Neuromodulation for Depression), nor as static magnets, nor as light therapy (Photobiomodulation: Research Overview). Other physical modalities are on Therapeutic Ultrasound and Other Physical Modalities: Evidence and Demand.What trials and reviews show
Knee and hand osteoarthritis
MixedA 2018 meta-analysis of 12 sham-controlled trials found less pain in knee and hand OA than sham, but not in neck OA; adverse events did not differ from sham [4]. A 2019 review of 8 trials (421 patients) in knee OA found improved physical function but no clear advantage on pain or stiffness [5]
Low back pain
Promising but limited14 trials (618 people): pain relief in chronic low back pain, not clearly in acute; no improvement in physical function [6]
Fresh fractures
No good evidence of benefit (for acute fractures)A 2024 systematic review of 3 randomized trials (197 patients) did not support PEMF for improving the bone healing process in acute fractures [7]
Delayed union and nonunion of long bones
Insufficient evidence from randomized trialsCochrane review of 4 trials (125 people): inconclusive and insufficient to inform practice; the pooled effect was not statistically significant [8]
Postoperative pain and swelling
Cleared category; trial evidence not assessed hereA regulatory category exists for an adjunct [3]; Proper evidence not found among the sources read
The nonunion result is notable: the bone-stimulator category is regulated, yet the randomized trials pooled in the Cochrane review were small and inconclusive. [1][8] Regulatory classification and randomized-trial certainty answer different questions.
Frequently asked questions
Is PEMF approved for anything?
In the United States, the FDA rules read here classify prescription non-invasive bone growth stimulators and nonthermal shortwave therapy for postoperative pain and edema as Class II devices with stated uses. [1][3]
Does PEMF heal fractures?
For fresh fractures, a 2024 systematic review did not support benefit. [7] For nonunions, randomized evidence is inconclusive. [8]
Does PEMF help arthritis or back pain?
Some meta-analyses show benefit for certain outcomes and some do not, so the evidence is mixed. [4][5][6]
Are PEMF mats and gadgets for "cellular energy" proven?
This page found no review supporting wellness claims for consumer products. That is a gap in what was read, not proof of harm or of no effect. See Claim Check: "FDA Registered" vs Product Approval.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
U.S. regulatory status (read 2026-10-22)
| Device type | What the FDA rule says | Notes |
|---|---|---|
| Non-invasive bone growth stimulator | A prescription device using electrical, magnetic or ultrasonic fields, used externally as an adjunct to fracture fixation and spinal fusion or for established nonunions or failed fusions; Class II with special controls [1] | Record shows the rule was published April 16, 2026; one original premarket approval in the FDA database has a 1979 decision date [1][2] |
| Nonthermal shortwave therapy | A prescription device applying pulsed radiofrequency energy for adjunctive palliative treatment of postoperative pain and edema of soft tissue, by means other than deep heat; Class II [3] | Does not cover wellness, arthritis or other claims |
The bone-stimulator labeling requirements include warnings for people with implanted medical devices and against use on compromised skin. [1] Clearance or approval applies to a named product and its use, so a different PEMF product sold for other purposes is not covered. Consumer PEMF mats and wearables were not reviewed individually and their status was not verified. Rules outside the United States were not verified; this is not legal advice.
Limitations common to this field
Who should check first
References
- U.S. Food and Drug Administration, eCFR. 21 CFR 890.5870, Non-invasive bone growth stimulator. Read 2026-10-22.
- U.S. Food and Drug Administration. Premarket Approval P790002, non-invasive bone growth stimulator. Read 2026-10-22.
- U.S. Food and Drug Administration, eCFR. 21 CFR 890.5290, Shortwave diathermy. Read 2026-10-22.
- Wu Z, et al. Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis. BMJ Open. 2018. Read 2026-10-22.
- Chen L, et al. Effects of pulsed electromagnetic field therapy on pain, stiffness and physical function in patients with knee osteoarthritis: a systematic review and meta-analysis. J Rehabil Med. 2019. Read 2026-10-22.
- Sun X, et al. Efficacy of pulsed electromagnetic field on pain and physical function in patients with low back pain: a systematic review and meta-analysis. Clin Rehabil. 2022. Read 2026-10-22.
- Picelli A, et al. Effects of pulsed electromagnetic fields on bone fractures: a systematic review update. Eur J Phys Rehabil Med. 2024. Read 2026-10-22.
- Griffin XL, et al. Electromagnetic field stimulation for treating delayed union or non-union of long bone fractures in adults. Cochrane Database Syst Rev. 2011. Read 2026-10-22.